These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6303803)

  • 1. Reverse stereoselectivity of opiate and benzodiazepine receptors for the opioid benzodiazepine tifluadom.
    Kley H; Scheidemantel U; Bering B; Müller WE
    Eur J Pharmacol; 1983 Mar; 87(4):503-4. PubMed ID: 6303803
    [No Abstract]   [Full Text] [Related]  

  • 2. Tifluadom-induced diuresis in rats. Evidence for an opioid receptor-mediated central action.
    Shearman GT; Tolcsvai L
    Neuropharmacology; 1986 Aug; 25(8):853-6. PubMed ID: 3022178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa-opiate-induced diuresis and changes in blood pressure: demonstration of receptor stereoselectivity using (+)- and (-)-tifluadom.
    Ureta H; López LF; Pérez A; Huidobro-Toro JP
    Eur J Pharmacol; 1987 Mar; 135(3):289-95. PubMed ID: 3034631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the opioid benzodiazepine tifluadom and its optical isomers on spontaneous locomotor activity of mice.
    Ruhland M; Zeugner H
    Life Sci; 1983; 33 Suppl 1():631-4. PubMed ID: 6319918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected opioid activity in a known class of drug.
    Römer D; Büscher HH; Hill RC; Maurer R; Petcher TJ; Zeugner H; Benson W; Finner E; Milkowski W; Thies PW
    Life Sci; 1982 Sep 20-27; 31(12-13):1217-20. PubMed ID: 6292610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the opioid-benzodiazepine, tifluadom, on ingestive behaviors.
    Morley JE; Levine AS; Grace M; Kneip J; Zeugner H
    Eur J Pharmacol; 1983 Sep; 93(3-4):265-9. PubMed ID: 6315453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa-opioid diuretic effects of tifluadom, a benzodiazepine opioid agonist.
    Leander JD
    J Pharm Pharmacol; 1984 Aug; 36(8):555-6. PubMed ID: 6148404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a kappa-agonist-like antinociceptive action of tifluadom.
    Upton N; Gonzalez JP; Sewell RD
    Neuropharmacology; 1983 Oct; 22(10):1241-2. PubMed ID: 6316195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locomotor depression by the opioid benzodiazepine tifluadom in mice.
    Castellano C; Pavone F; Sansone M
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):318-23. PubMed ID: 6091579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of chloroquine with benzodiazepine, gamma-aminobutyric acid and opiate receptors.
    Liu L; Katz Y; Weizman R; Rosenberg B; Pasternak GW; Gavish M
    Biochem Pharmacol; 1991 May; 41(10):1534-6. PubMed ID: 1850280
    [No Abstract]   [Full Text] [Related]  

  • 11. Tifluadom (KC 5103) induces suppression and latency changes on somatosensory evoked potentials which are reversed by opioid antagonists.
    Freye E; Hartung E; Schenk GK
    Life Sci; 1983; 33 Suppl 1():537-40. PubMed ID: 6319908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid benzodiazepine tifluadom and drug-induced hyperactivity in mice: lack of benzodiazepine-like effects.
    Sansone M; Castellano C; Pavone F; Hano J
    Pol J Pharmacol Pharm; 1985; 37(5):585-90. PubMed ID: 2870483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine recognition sites on GABA receptors.
    Gavish M; Snyder SH
    Nature; 1980 Oct; 287(5783):651-2. PubMed ID: 6253806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antagonism of benzodiazepine binding to cerebral receptors by H1 and H2 antihistamines.
    Speeg KV; Wang S; Avant GR; Parker R; Schenker S
    J Lab Clin Med; 1981 Jan; 97(1):112-2. PubMed ID: 6108979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tifluadom on passive avoidance behaviour in DBA/2 mice.
    Pavone F; Castellano C
    Behav Brain Res; 1985 May; 15(3):177-81. PubMed ID: 2988580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benzodiazepine (+)-tifluadom (KC-6128), but not its optical isomer (KC-5911) induces opioid kappa receptor-related EEG power spectra and evoked potential changes.
    Freye E; Boeck G; Schaal M; Ciaramelli F
    Pharmacology; 1986; 33(5):241-8. PubMed ID: 3025899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of opioid subtypes compared with benzodiazepines in the staircase paradigm.
    Milman A; Weizman R; Rigai T; Rice KC; Pick CG
    Behav Brain Res; 2006 Jun; 170(1):141-7. PubMed ID: 16574254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepines modify the agonist responses at a presynaptic GABA receptor.
    Mitchell R
    Eur J Pharmacol; 1980 Dec; 68(3):369-72. PubMed ID: 6110546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepine receptor ligand actions on GABA responses. Benzodiazepines, CL 218872, zopiclone.
    Skerritt JH; Macdonald RL
    Eur J Pharmacol; 1984 May; 101(1-2):127-34. PubMed ID: 6086357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.